Thermogenesis Holdings Inc.

09/14/2021 | Press release | Distributed by Public on 09/14/2021 06:38

ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies